Targeting Antiapoptotic Bcl-2 Family Members with Cell-Permeable BH3 Peptides Induces Apoptosis Signaling, Death in Head, Neck Squamous Cell Carcinoma Cells

This publication has 62 references indexed in Scilit:

• Apoptosis Initiated When BH3 Ligands Engage Multiple Bcl-2 Homologs, Not Bax or Bak
  Science, 2007
• Nuclear factor-κB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101
  Molecular Cancer Therapeutics, 2007
• (−)-Gossypol Inhibits Growth and Promotes Apoptosis of Human Head and Neck Squamous Cell Carcinoma In Vivo
  Neoplasia, 2006
• The role of cetuximab in the treatment of squamous cell cancer of the head and neck
  Expert Opinion on Biological Therapy, 2005
• Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy
  Cancer Biology & Therapy, 2005
• Reversal of cisplatin resistance with a BH3 mimetic, (−)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL
  Molecular Cancer Therapeutics, 2005
• Rational Design and Real Time, In-Cell Detection of the Proapoptotic Activity of a Novel Compound Targeting Bcl-XL
  Chemistry & Biology, 2004
• Cell Death
  Cell, 2004
• Minimal BH3 Peptides Promote Cell Death by Antagonizing Anti-apoptotic Proteins
  Journal of Biological Chemistry, 2003
• Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
  Cell, 1996